TN 3 (02-10)

DI 23022.515 Thanatophoric Dysplasia, Type 1

THANATOPHORIC DYSPLASIA, TYPE 1

ALTERNATE NAMES

TD1; TDI; Dwarf, Thanatophoric; Thanatophoric Dwarfism; Thanatophoric Short Stature

DESCRIPTION

Thanatophoric Dysplasia Type 1 (TD1) is a severe skeletal disorder characterized by a normal-shaped skull, curved thigh bones and flattened bones of the spine (platyspondyly). The term thanatophoric is Greek for “death bearing”. Infants with TD1 are usually stillborn or die shortly after birth from respiratory failure; however, a few affected individuals have survived into childhood with extensive medical help. This disorder is caused by mutations in the FGFR3 gene. The gene provides instructions for making a protein that is involved in the development and maintenance of bone and brain tissue. Mutations in this gene cause the FGFR3 protein to be overly active, which leads to the severe disturbances in bone growth. This condition occurs in 1 in 20,000 to 50,000 newborns.

DIAGNOSTIC

TESTING, PHYSICAL FINDINGS, AND ICD-9-CM CODING

Clinical examination, prenatal ultrasound with findings of growth deficiency, ventriculomegaly, macrocephaly, well-ossified skull and spine, platyspondyly of the vertebrae, micromelia, bowed femurs, narrow chest cavity with shortened ribs and polyhydramnios. Molecular genetic testing of the gene FGFR3.

ICD-9: 756.4 Chondrodystrophy

ONSET AND PROGRESSION

Newborns with TD1 are stillborn or die shortly after birth. Very rare reports of survival into early childhood have been cited. Long-term survivors need neurologic, orthopedic, and audiologic evaluations, CT to monitor for craniocervical constriction, and EEG to monitor for seizure activity.

TREATMENT

Treatment measures of the few survivors may include: antiepileptic drugs to control seizures, shunt placement for hydrocephaly, suboccipital decompression for relief of craniocervical junction constriction, and hearing aids.

SUGGESTED PROGRAMMATIC ASSESSMENT*

Suggested MER for Evaluation: Clinical examination, ultrasound, audiological evaluation, genetic testing, and imaging studies.

Suggested Listings for Evaluation:

DETERMINATION

LISTING

REMARKS

Meets Listing

110.08 B

 

Medical Equals

  

* Adjudicators may, at their discretion, use the Medical Evidence of Record or Listings suggested to evaluate the claim. However, the decision to allow or deny the claim rests with the adjudicator.


To Link to this section - Use this URL:
http://policy.ssa.gov/poms.nsf/lnx/0423022515
DI 23022.515 - Thanatophoric Dysplasia, Type 1 - 02/26/2010
Batch run: 02/26/2010
Rev:02/26/2010